Safety and Immunogenicity of Live Attenuated Herpes Zoster Vaccine in Patients Undergoing Living Donor Kidney Transplantations.
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 04 May 2017
At a glance
- Drugs Varicella zoster virus vaccine live (Primary)
- Indications Herpes zoster
- Focus Pharmacodynamics
- 26 May 2015 Planned End Date changed from 1 Dec 2013 to 1 Dec 2016 as per ClinicalTrials.gov record.
- 26 May 2015 Status changed from recruiting to active, no longer recruiting as per ClinicalTrials.gov record.
- 16 Apr 2012 Planned end date changed from 1 Dec 2012 to 1 Dec 2013 as reported by ClinicalTrials.gov.